Compugen is transforming the pathway to immuno-oncology therapeutics with Unigen™, a unique flexible-loop platform that integrates deep scientific knowledge and AI/ML innovation to pioneer novel targets and first-in-class drugs
Our potentially first-in-class therapeuticantibodies targeting novel pathways arecurrently being evaluated in multiple clinical trials
Join our team of leading research experts and drug developers that discover novel drug targets and develop treatments to extend the reach of immunotherapies.
View Open Positions